Zhongze Therapeutics announces exclusive license of DGX-001 with Digestome Therapeutics for Greater China
Client(s) Zhongze Therapeutics (Cayman) Holding Limited
Jones Day represented Zhongze Therapeutics (Cayman) Holding, Ltd. in an exclusive license and collaboration agreement with Digestome Therapeutics, Inc. to develop, manufacture, and commercialize Digestome's first-in-class oral therapeutic ALT-100 in the Greater China territory.